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Background & aims: Dietary chloroplast thylakoids have previously been found to reduce food intake and
body weight in animal models, and to change metabolic proﬁles in humans in mixed-food meal studies.
The aim of this study was to investigate the modulatory effects of thylakoids on glucose metabolism and
appetite-regulating hormones during an oral glucose tolerance test in pigs fed a high fat diet.
Methods: Six pigs were fed a high fat diet (36 energy% fat) for one month before oral glucose tolerance
test (1 g/kg D-glucose) was performed. The experiment was designed as a cross-over study, either with or
without addition of 0.5 g/kg body weight of thylakoid powder.
Results: The supplementation of thylakoids to the oral glucose tolerance test resulted in decreased blood
glucose concentrations during the ﬁrst hour, increased plasma cholecystokinin concentrations during the
ﬁrst two hours, and decreased late postprandial secretion of ghrelin.
Conclusion: Dietary thylakoids may be a novel agent in reducing the glycaemic responses to high car-
bohydrate and high glycaemic index foods. Thylakoids may in the future be promising for treatment and
prevention of diabetes, overweight and obesity.
 2013 The Authors. Published by Elsevier Ltd and European Society for Clinical Nutrition and
Metabolism. All rights reserved.1. Introduction
The global obesity epidemic continuous to increase, with 65% of
the world’s population living in countries where obesity and
overweight cause more death than underweight.1a The increased
intake of palatable food rich in fat and reﬁned carbohydrates,
together with the decreased physical activity, are the main causes
for obesity and overweight.1a,1,2 Moreover, appetite control is easily
deviated with palatable food.3,4 Thus, to counteract the obesity
epidemic, focus on endocrine appetite signals for cravings of
palatable foods, as well as focus on physical activity, are essential.
The body weight is fundamentally regulated by food intake andcose tolerance test; AUC, area
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Published by Elsevier Ltd and Eurenergy expenditure. Several hormones are responsible for the
regulation of food intake, such as ghrelin, cholecystokinin (CCK)
and leptin.5,6 The energy expenditure on the other hand is regu-
lated by physical activity, the basal metabolic rate and thermo-
genesis. Therefore, reduction of body weight requires control of
food intake and a change in energy expenditure.7,8
The use of dietary thylakoids, extracted from chloroplasts in
green leaves, as satiety-strengthening food components have pre-
viously been described.1,3,5,9e12 Thylakoids have demonstrated an
effect on body-weight gain, decreased food intake as well as
decreased percentage of body fat in mice and rats.9,10,12 In vitro,
thylakoids prolong the uptake of glucose and the decrease the
passage of macromolecules over the rat intestinal wall.13,14 The
addition of thylakoids for 10 days in rat resulted in an altered
microﬂora and decreased plasmaeinsulin response to an oral
glucose tolerance test of the 10th day, while levels of blood glucose
were unchanged.12,14 Moreover, thylakoids have been shown to
decrease the lipase activity both in vitro11,15 and in vivo in pig.1 In
humans, supplementation of a high dose of thylakoids to a high-fatopean Society for Clinical Nutrition and Metabolism. All rights reserved.
Fig. 1. Blood glucose following an oral glucose tolerance test (OGTT) in pigs, with or
without supplementation of 0.5 g/kg body weight of thylakoids, resulted in signiﬁ-
cantly lower blood glucose levels the ﬁrst hour, and no late postprandial hypo-
glycaemia (120e360 min) following the thylakoid OGTT (B), compared to the control
OGTT (:) (p < 0.05, calculated with AUC). Data are mean  SEM, in a cross-over design
in six pigs. Statistical differences between thylakoid and control OGTT is indicated by
**p < 0.01 and ***p < 0.001 (calculated with Bonferroni corrected 2-way Anova).
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free fatty acids and the hunger hormone ghrelin, and simulta-
neously elevate plasma concentrations of the satiety hormone
CCK.3 A high-carbohydrate meal supplemented of with a low dose
of thylakoids resulted in an increased plasma concentration of
glucose, insulin and CCK two hours after start of the meal.5
Since previous effects on blood glucose and insulin are not clear,
the aim of the present study was to clarify the effect of thylakoid
supplementation on glucose metabolism and to investigate the
effect on the appetite-regulating hormones as CCK and ghrelin
further in pigs, who had consumed a high fat diet for four weeks (to
mimic the westernized food-habits).
2. Materials and methods
2.1. Animals
The experiments were performed on crossbred pigs
((Yorkshire  Swedish Landrace)  Hampshire) obtained from
Odarslöv research farm, belonging to the Swedish University of
Agricultural Sciences (Alnarp, Sweden). The pigs were 11 weeks old
with an average body weight of 13.7  1.1 kg at the start of the
experiment. The pigs were transported to the departments’ animal
facilities one month before start of the experiment, at the age of 7
weeks, and were fed 4% of their body weight/day of a high fat diet.
The diet consisted of 75% of a conventional pig chow (Växtill 320,
Lantmännen, Malmö, Sweden), mixed with 17% fresh milk cream
(40% fat, Skånemejerier, Malmö, Sweden) and 8% rapeseed oil
(Eldorado, Axfood, Solna, Sweden). The energy distribution of the
high fat diet was 36 E% fat, 14 E% protein and 50 E% carbohydrate.
National guidelines for the care and use of pigs were followed and
all experimental procedures were approved by the Ethical Com-
mittee of Animal Experiments at Lund University (M93-11).
One week after adaptation to the animal facilities, the pigs were
implanted with a jugular vein catheter, as described earlier.7
2.2. Thylakoids and Oral Glucose Tolerance Test (OGTT)
Thylakoids used in the present study were prepared from dry
spinach leaves using the pH-method, as describedby.9 The thylakoid-
slurrywas drumdried to obtain a thylakoid powder, namedAppethyl,
donated by Green Leaf Medicals AB (Stockholm, Sweden).
Prior to the OGTT, pigs had been fasted overnight for approxi-
mately 18 h. Feeding was carried out via a syringe directly in the
mouth during approximately 1min. The oral glucose load consisted
of 1 g/kg body weight of a 20% D-glucose solution, with or without
supplementation of 0.5 g/kg bodyweight of thylakoids. Pigs had free
access to tap water at all times. The test was a cross-over design, i.e.
all pigs received one day of control OGTT and one day of thylakoid
supplemented OGTT, separated by a wash-out of two days.
Baseline blood samples were taken from the jugular catheter
before oral glucose loads were administered (time 0 min), and
thereafter repeatedly during the day at 15, 30, 45, 60, 90, 120, 180,
240 and 360 min. In between blood sampling, the jugular catheter
was ﬂushed with saline (0.9% sodium chloride). Blood were
collected into EDTA-tubes (6 mL), that were gently inverted several
times after collection and stored on ice before being centrifuged
3000  g for 15 min at 4 C. Plasma samples were stored in cryo-
genic tubes at20 before the insulin analysis (performed one week
after the end of the experiment), and then at 80 C.
2.3. Biochemical analysis
Blood glucose was analysed directly using a glucose-meter
(ACCU-CHECK Aviva, Roche Diagnostics A/S, Hvidovre, Denmark).Plasma insulin was analysed using an ELISA-kit for Porcine In-
sulin (10-1200-01, detection limit 0.01 mg/L, Mercodia AB, Uppsala,
Sweden). Plasma CCK were measured using a radioimmunoassay
(RIA) with a highly speciﬁc antiserum (no. 92128, detection limit
0.1 pmol/L).16 Plasma ghrelin were measured using an RIA kit that
recognises both the acylated and desacylated forms of the porcine
hormone (RK-031-52, detection limit 10 pg/mL, Phoenix Pharma-
ceuticals GmbH, Karlsruhe, Germany).
2.4. Statistics
Statistical data analyses were done using Prism, version 6
(GraphPad Software, Inc, San Diego, CA, USA). Bonferroni corrected
two-way Anova was used to calculate statistical differences be-
tween time points. For total comparison between thylakoid and
control OGTT, both two-way Anova and numerical calculations of
area under the curve (AUC) were used. Data were treated as not
being normally distributed. All data are expressed as mean  SEM.
P-values <0.05 were considered to be statistically signiﬁcant, and
p-values <0.1 to be of interest to mention.
3. Results
The thylakoid supplemented OGTT, given orally to pigs, affected
the outcome of blood glucose, plasma insulin and the hunger and
satiety-regulating hormones ghrelin and CCK (Figs. 1e4).
Following the control OGTT, blood glucose concentrations were
rapidly elevated and reached the highest level after 30 min (Fig. 1).
Thereafter, a steep decrease was observed, and glucose concen-
trations below fasting levels were observed from 120min. After the
thylakoid supplemented OGTT, glucose concentrations initially
increased rapid, but signiﬁcantly lower peak concentrations were
found at 30 min (p < 0.01) and 45 min (p < 0.001) compared to the
control. The thylakoid supplemented OGTT in the later phase,
measured with AUC between 120 and 360 min, resulted in blood
glucose concentrations not below fasting levels, compared to after
the control OGTT (control: 980 mmol/L vs. thylakoid: 1225mmol/L;
p < 0.05).
The plasma (p) insulin concentrations increased rapidly
following the control OGTT, reaching the highest level after
30 min (Fig. 2). Thereafter, the concentrations decreased and
returned to fasting concentrations at 120 min. The supplementa-
tion of thylakoids resulted in similar p-insulin concentrations
during the ﬁrst 60 min, with slightly lower concentrations found at
15 min and 30 min (p < 0.1), compared to control. Thereafter, the
Fig. 2. Plasma insulin following an oral glucose tolerance test (OGTT) in pigs, with or
without supplementation of 0.5 g/kg body weight of thylakoids, resulted in lower
levels of p-insulin during the ﬁrst hour, and elevated levels from 120 to 360 min after
the thylakoid OGTT (B) compared to the control OGTT (:) (p < 0.1, calculated with
AUC). Data are mean  SEM, in a cross-over design in six pigs.
Fig. 4. Secretion of plasma ghrelin after an oral glucose tolerance test (OGTT) in pigs
with or without supplementation of 0.5 g/kg body weight of thylakoids, resulted in
signiﬁcantly decreased levels of p-ghrelin from 120 to 240 min following the thylakoid
OGTT (B), compared to control OGTT (:). The secretion of p-ghrelin was also sup-
pressed during the complete time period of 0e360 min for the thylakoid OGTT,
compared to the control OGTT (p < 0.1, calculated with AUC). Data are mean  SEM, in
a cross-over design in six pigs. Statistical differences between thylakoid and control
OGTT is indicated by **p < 0.01 and ***p < 0.001 (calculated with Bonferroni corrected
2-way Anova).
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signiﬁcantly different, p-insulin concentrations for the thylakoid
supplemented OGTT compared to the control OGTT (control:
2.54 mg/L vs. thylakoid: 7.64 mg/L; p < 0.1).
The concentrations of p-CCK increased rapidly after the control
OGTT, peaking at 15 min, subsequently, the concentrations
decreased immediately to fasting levels (Fig. 3). The thylakoid
supplemented OGTT resulted in a signiﬁcantly higher p-CCK con-
centration than control, being optimal at 30 min (p < 0.05), and
continued to be increased during the following three hours. An
increased CCK secretion during the entire experimental time, 0e
360 min, was found following the thylakoid OGTT compared to the
control OGTT, measured with AUC (control: 1415 pmol/L vs. thyla-
koid: 1852 pmol/L; p < 0.1).
The concentrations of p-ghrelin after the control OGTT
decreased during the ﬁrst hour, and thereafter increase above
fasting levels in the 120e240 min interval (Fig. 4). With the addi-
tion of thylakoids, p-ghrelin concentrations decreased during the
ﬁrst hour, and stayed signiﬁcantly lower at 120 min (p < 0.001),
180 min (p < 0.001) and 240 min (p < 0.001), compared to the
control OGTT. The AUC between 0 and 360 min was lower, but not
signiﬁcantly different, after the thylakoid supplemented OGTT,
compared to the control OGTT (control: 51,108 pg/mL vs. thylakoid:
40,971 pg/mL; p < 0.1).Fig. 3. Secretion of plasma cholecystokinin (CCK) after an oral glucose tolerance test
(OGTT) in pigs with or without supplementation of 0.5 g/kg body weight of thylakoids,
resulted in signiﬁcantly increased levels of p-CCK 30 min after the thylakoid OGTT (B),
compared to the control OGTT (:). The secretion of p-CCK was also increased during
the complete time period of 0e360 min for the thylakoid OGTT, compared to control
OGTT (p < 0.1, calculated with AUC). Data are mean  SEM, in a cross-over design in six
pigs. Statistical differences between thylakoid and control OGTT is indicated by
*p < 0.05 (calculated with Bonferroni corrected 2-way Anova).4. Discussion
In this study we have found that the addition of thylakoids to an
OGTT given to pigs, fed a high fat diet for four weeks, modify the
postprandial concentrations of blood glucose, p-CCK and p-ghrelin
in a signiﬁcant manner, so as to promote glucose and energy
balance.
The blood glucose-response after an OGTT is normally increased
rapidly and then decreased below the concentrations found in the
fasting state, as was also the case for the control OGTT in the pre-
sent study. However, in the presence of thylakoids, the blood
glucose concentrations did not increase to the same magnitude,
and there was no postprandial hypoglycaemia. The supplementa-
tion of thylakoids thereby resulted in a similar blood glucose-
response as can be seen after the consumption of a low GI-food.13
The present study have thus shown that thylakoids have an effect
on the blood glucose metabolism. We have previously shown in an
in vitromodel using rat small intestine in Ussing chambers, that the
addition of thylakoids prolong the uptake of glucose signiﬁcantly.14
This was explained by the formation of an extra “membrane” seen
with electron micrograph. This membrane can be formed since
thylakoids expose both hydrophilic and hydrophobic surface
groups, and these surface properties allow strong interaction with
the intestinal surface. As thylakoids cover the intestinal mucosa, a
prolongation of both the active and passive passage of glucose over
the intestinal wall can be explained.14 In addition, thylakoids was
found to have an afﬁnity of 17% to glucose, which also could, in part,
explain a prolonged uptake since glucose would stay in the GI-tract
for a longer time period. The similar phenomenonwith a formation
of a “thylakoid barrier” and binding to glucose would explain the
present in vivo results.
The changed p-insulin levels after the addition of thylakoids
reﬂect the lower but prolonged blood glucose concentrations.
Taken together, the changed glucose and insulin curves after
addition of thylakoids, compared to the control OGTT, indicate that
dietary supplementation of thylakoids could be beneﬁcial for sup-
pressing the incidence of diabetes.13
CCK has been considered an important satiety hormone for
years. The regulation of CCK secretion is similar in pigs and humans,
and is stimulated both by carbohydrates, proteins and fat.17,18 The
effects of CCK include stimulation of pancreatic secretion of en-
zymes, pancreatic growth, gallbladder emptying, as well as control
of gut motility and gastric emptying. The present results show a
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following the OGTT with addition of thylakoids, as compared to the
control OGTT. The increased CCK secretion seen in our previous
studies have been explained by the prolonged lipolysis caused by
the accumulation of thylakoids at the surface of lipid droplets, as
well as binding of thylakoids to lipase/colipase.10 The secretion of
CCK has previously been found to be increased as a response to low
GI foods.19 This was explained by a slower rate of gastric emptying
and hence entry of carbohydrates into the proximal small intestine
after intake of low GI foods compared to high GI foods, prolonging
the stimulation of the CCK-secreting I cells.19 The stimulation of I
cells would further decrease gastric emptying and thereby prolong
the CCK secretion. The same mechanistic explanation could theo-
retically explain how thylakoids may affect the secretion of CCK
after an OGTT. The present results of thylakoids effect on CCK
secretion does support our previous ﬁndings that thylakoids pro-
mote a continuous release of CCK for a prolonged time after nu-
trients have reached the stomach and intestines,3,10 and that these
effects are not only achieved by the fat content, but also by
carbohydrates.
In recent years, the role of ghrelin to regulate pre-prandial
hunger has been discussed. It has been reported that ghrelin
administered systemically in doses mimicking basal plasma con-
centrations stimulates food intake in a broad range of animals.20
Postprandially, when macronutrient composition and volume are
kept constant, ghrelin is suppressed in proportion to the calories
ingested.21 Moreover, carbohydrates and proteins have been found
to promote the ghrelin suppression post-prandially more potently
than fat.22,23 Present results of a postprandial suppression of the
ghrelin secretion may be explained by the prolonged gastric
emptying, as discussed regarding CCK above. Since ghrelin is pri-
marily synthesised and secreted from endocrine cells in the gastric
fundus,20 a prolonged gastric emptying would theoretically blunt
the synthesis and secretion of ghrelin as thylakoids was added to
the OGTT. In long-term regulation of body weight and increased
adiposity, ghrelin has also been found to play a crucial role, as ro-
dents given chronic administration gain weight and have an
increased stimulation of adipogenesis as long as the administration
continuous.20,24 The postprandial suppression of p-ghrelin found in
the present study demonstrates that the supplementation of thy-
lakoids may be important for suppression of hunger, and thereby
might be useful for suppression of overweight and adiposity.
Control of the secretion of gut hormones, such as ghrelin and
CCK, are of greatest interest for long-term approaches to control
weight and counteract metabolic diseases, without deleterious side
effects.25,26 The present study demonstrates that the addition of
thylakoids to glucose inﬂuences the release of relevant gut hor-
mones, by increasing the secretion of p-CCK, and suppressing the
late post-prandial secretion of p-ghrelin. Moreover, the addition of
thylakoids lowered the blood glucose curve, similar to curves seen
after ingesting a low GI-food. With lower blood glucose and insulin
responses in daily life, the risk of cardiovascular disease and the
prevalence of diabetes type 2 and of obesity is diminished.13 If
thylakoids have the same effects in overweight/obese/healthy
humans, and in diabetic/pre-diabetic patients, as shown in the
present study will be addressed in the future. However, several
longer studies have been performed in mice and rats, showing that
the addition of thylakoids to the diet, for a time period of 10e100
days, does affect the ad libitum food intake, body weight gain, body
composition and several metabolic proﬁles such as glucose, insulin,
free fatty acids, triglycerides, leptin and CCK.9e12 The proposed
mechanisms of action for thylakoids are 1) a prevention of post-
prandial hypoglycaemia by a prolonged uptake of glucose through
both a direct binding of glucose to thylakoids, and a binding of
thylakoids to the gastric and intestinal mucosa, 2) a possibleinterference by thylakoids to the small intestinal mucosa affecting
the direct release of gut hormones, and 3) a delayed gastric
emptying affecting secretion of CCK and ghrelin.
In summary, the present study shows that thylakoids affect in-
testinal glucose absorption and the secretion of major gut hor-
mones involved in appetite regulation, such as CCK and ghrelin,
after an OGTT in pigs. We suggest thylakoids as a promising novel
food component for reducing the glycaemic index after a high-
carbohydrate load and in high glycaemic foods. Thylakoids may
therefore in the future be useful for prevention of diabetes, over-
weight and obesity.
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